Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin’s lymphoma

por Ferrucci, PF, Vanazzi, A, Crosta, C, Pruneri, G, Grana, C, Bartolomei, M, Paganelli, G, Martinelli, G
Publicado 2008

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer

por Ferrucci, PF, Rabascio, C, Corsini, C, Tealdo, F, Paolucci, M, Bertolini, F, El Taani, H, Martinelli, G
Publicado 2000

Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience

por Cocorocchio, E, Gandini, S, Alfieri, S, Battaglia, A, Pennacchioli, E, Tosti, G, Spadola, G, Barberis, M, Leo, M Di, Riviello, C, Pala, L, Intelisano, A, Martinoli, C, Ferrucci, PF
Publicado 2016

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

por Ascierto, Paolo Antonio, Simeone, E, Sileni, V Chiarion, Queirolo, P, Del Vecchio, M, Di Guardo, L, Guidoboni, M, Marchetti, P, Cappellini, GC Antonini, Ferrucci, PF, Cognetti, F, Bernengo, MG, Guida, M, Marconcini, R, Mandalà, M, Cimminiello, C, Rinaldi, G, Aglietta, M, Calabrò, L, Maio, M
Publicado 2013